{"id":"https://openalex.org/W2397543233","doi":"https://doi.org/10.1002/cpt1977214470","title":"Influence of rifampicin on drug metabolism: Differences between hexobarbital and antipyrine","display_name":"Influence of rifampicin on drug metabolism: Differences between hexobarbital and antipyrine","publication_year":1977,"publication_date":"1977-04-01","ids":{"openalex":"https://openalex.org/W2397543233","doi":"https://doi.org/10.1002/cpt1977214470","mag":"2397543233","pmid":"https://pubmed.ncbi.nlm.nih.gov/849678"},"language":"en","primary_location":{"id":"doi:10.1002/cpt1977214470","doi":"https://doi.org/10.1002/cpt1977214470","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt1977214470","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109127184","display_name":"Douwe D. Breimer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]},{"id":"https://openalex.org/I25974101","display_name":"University of W\u00fcrzburg","ror":"https://ror.org/00fbnyb24","country_code":"DE","type":"education","lineage":["https://openalex.org/I25974101"]}],"countries":["DE","NL"],"is_corresponding":false,"raw_author_name":"D. D. Breimer","raw_affiliation_strings":["Department of Pharmacology, Subfaculty of Pharmacy, University of Leiden, and Department of Internal Medicine, University of Wu\u0308rzburg, Leiden, The Netherlands, and Wu\u0308rzburg, German Federal Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Subfaculty of Pharmacy, University of Leiden, and Department of Internal Medicine, University of Wu\u0308rzburg, Leiden, The Netherlands, and Wu\u0308rzburg, German Federal Republic","institution_ids":["https://openalex.org/I121797337","https://openalex.org/I25974101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072224428","display_name":"Walter Zilly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]},{"id":"https://openalex.org/I25974101","display_name":"University of W\u00fcrzburg","ror":"https://ror.org/00fbnyb24","country_code":"DE","type":"education","lineage":["https://openalex.org/I25974101"]}],"countries":["DE","NL"],"is_corresponding":false,"raw_author_name":"W. Zilly","raw_affiliation_strings":["Department of Pharmacology, Subfaculty of Pharmacy, University of Leiden, and Department of Internal Medicine, University of Wu\u0308rzburg, Leiden, The Netherlands, and Wu\u0308rzburg, German Federal Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Subfaculty of Pharmacy, University of Leiden, and Department of Internal Medicine, University of Wu\u0308rzburg, Leiden, The Netherlands, and Wu\u0308rzburg, German Federal Republic","institution_ids":["https://openalex.org/I121797337","https://openalex.org/I25974101"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012534532","display_name":"Erik Arne Richter","orcid":"https://orcid.org/0000-0002-6850-3056","observed_orcids":["https://orcid.org/0000-0002-6850-3056"]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]},{"id":"https://openalex.org/I25974101","display_name":"University of W\u00fcrzburg","ror":"https://ror.org/00fbnyb24","country_code":"DE","type":"education","lineage":["https://openalex.org/I25974101"]}],"countries":["DE","NL"],"is_corresponding":false,"raw_author_name":"E. Richter","raw_affiliation_strings":["Department of Pharmacology, Subfaculty of Pharmacy, University of Leiden, and Department of Internal Medicine, University of Wu\u0308rzburg, Leiden, The Netherlands, and Wu\u0308rzburg, German Federal Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Subfaculty of Pharmacy, University of Leiden, and Department of Internal Medicine, University of Wu\u0308rzburg, Leiden, The Netherlands, and Wu\u0308rzburg, German Federal Republic","institution_ids":["https://openalex.org/I121797337","https://openalex.org/I25974101"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":4.4176,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.95197319,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"21","issue":"4","first_page":"470","last_page":"481"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":1.0},{"id":"https://openalex.org/keywords/drug-metabolism-induction","display_name":"drug metabolism induction","score":0.7760000228881836},{"id":"https://openalex.org/keywords/hexobarbital","display_name":"hexobarbital","score":0.8050000071525574},{"id":"https://openalex.org/keywords/antipyrine","display_name":"antipyrine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/indocyanine-green","display_name":"indocyanine green","score":0.7770000100135803},{"id":"https://openalex.org/keywords/galactose-elimination","display_name":"galactose elimination","score":0.8389999866485596},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.9010000228881836},{"id":"https://openalex.org/keywords/metabolic-clearance","display_name":"metabolic clearance","score":0.9629999995231628},{"id":"https://openalex.org/keywords/oxidative-drug-metabolism","display_name":"oxidative drug metabolism","score":0.734000027179718},{"id":"https://openalex.org/keywords/d-glucaric-acid","display_name":"D-glucaric acid","score":0.7829999923706055},{"id":"https://openalex.org/keywords/gamma-glutamyl-transferase","display_name":"gamma-glutamyl transferase","score":0.8939999938011169},{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.47099998593330383},{"id":"https://openalex.org/keywords/hepatic-clearance","display_name":"hepatic clearance","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2777466164","wikidata":"https://www.wikidata.org/wiki/Q421183","display_name":"Hexobarbital","level":4,"score":0.9311649799346924},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.8212655186653137},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6154221892356873},{"id":"https://openalex.org/C89311334","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Drug metabolism","level":3,"score":0.571913480758667},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5572298765182495},{"id":"https://openalex.org/C2781065829","wikidata":"https://www.wikidata.org/wiki/Q905662","display_name":"Indocyanine green","level":2,"score":0.5325143933296204},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5310806632041931},{"id":"https://openalex.org/C192670549","wikidata":"https://www.wikidata.org/wiki/Q5361061","display_name":"Elimination rate constant","level":4,"score":0.48306921124458313},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.46788543462753296},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.44449272751808167},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.42181485891342163},{"id":"https://openalex.org/C10146269","wikidata":"https://www.wikidata.org/wiki/Q185557","display_name":"Excretion","level":2,"score":0.41591715812683105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40095093846321106},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3851316571235657},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2952592968940735},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.1468622088432312},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.12601420283317566},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12024101614952087},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.08648514747619629},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.05588209629058838},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000983","descriptor_name":"Antipyrine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005690","descriptor_name":"Galactose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006591","descriptor_name":"Hexobarbital","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007208","descriptor_name":"Indocyanine Green","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/cpt1977214470","doi":"https://doi.org/10.1002/cpt1977214470","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt1977214470","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:849678","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/849678","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1964758561","https://openalex.org/W2440354756","https://openalex.org/W2061357234","https://openalex.org/W2465204502","https://openalex.org/W2472695019","https://openalex.org/W2119613706","https://openalex.org/W2070392100","https://openalex.org/W303880824","https://openalex.org/W2226961199","https://openalex.org/W2077006449"],"abstract_inverted_index":{"Six":[0],"healthy":[1],"volunteers":[2],"were":[3,39],"treated":[4,97],"with":[5,98,136],"1,200":[6],"mg":[7],"of":[8,36,49,72,164],"rifampicin":[9,99,132,159],"daily":[10],"for":[11],"8":[12],"days.":[13,32],"Before":[14],"and":[15,24,58,82,85,147],"immediately":[16],"afterward":[17],"each":[18],"received":[19],"indocyanine":[20,110],"green,":[21],"hexobarbital,":[22],"galactose,":[23],"antipyrine":[25,73,101],"by":[26],"intravenous":[27],"infusion":[28],"on":[29,78],"3":[30],"consecutive":[31],"The":[33,45,134],"plasma":[34],"concentrations":[35],"the":[37,68,76,100],"drugs":[38],"determined":[40],"several":[41],"times":[42],"after":[43,140],"infusion.":[44],"average":[46,69],"elimination":[47,70,102,115],"half-life":[48,71],"hexobarbital":[50,137],"had":[51,62,150],"decreased":[52],"from":[53],"407":[54],"to":[55,152],"171":[56],"min":[57],"its":[59],"metabolic":[60,91],"clearance":[61,112,148],"increased":[63,130],"almost":[64],"threefold.":[65],"In":[66,93],"contrast,":[67],"was":[74,87,104,121,129,138],"virtually":[75],"same":[77],"both":[79],"occasions":[80],"(6.9":[81],"7.2":[83],"hr)":[84],"there":[86],"no":[88],"change":[89],"in":[90,143,168],"clearance.":[92],"a":[94,161],"tuberculous":[95],"patient":[96],"rate":[103],"unaffected.":[105],"Rifampicin":[106],"did":[107],"not":[108,122],"influence":[109],"green":[111],"or":[113],"galactose":[114],"capacity.":[116],"Serum":[117],"gamma":[118],"glutamyl":[119],"transferase":[120],"affected":[123],"but":[124],"urinary":[125],"D-glucaric":[126],"acid":[127],"excretion":[128],"during":[131],"treatment.":[133],"experiment":[135],"repeated":[139],"2":[141],"weeks":[142],"all":[144],"subjects;":[145],"half-lives":[146],"values":[149],"returned":[151],"near":[153],"control":[154],"values.":[155],"It":[156],"appears":[157],"that":[158],"is":[160],"selective":[162],"inducer":[163],"oxidative":[165],"drug":[166],"metabolism":[167],"man.":[169]},"counts_by_year":[{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}